The potential TF binding sites and drugs targeting three genes were predicted, which initially provides a systematically comprehensive analysis of m6A-related autophagy genes in NAFLD and predicts potential agents for the treatment of NAFLD. This evidence concerns the gene TF and metabolic dysfunction-associated steatotic liver disease.